Genentech, OSI Pharmaceuticals report positive Phase III cancer study results
Saturn is a placebo-controlled, randomized, double-blind, Phase III study conducted by Roche that enrolled 889 patients with advanced non-small cell lung cancer (NSCLC) at approximately 160 sites worldwide.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.